scholarly journals Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

2018 ◽  
Vol 29 ◽  
pp. viii258 ◽  
Author(s):  
A. Hollebecque ◽  
M. Borad ◽  
V. Sahai ◽  
D.V.T. Catenacci ◽  
A. Murphy ◽  
...  
1996 ◽  
Vol 271 (10) ◽  
pp. 5663-5670 ◽  
Author(s):  
Agnes Estival ◽  
Veronique Monzat ◽  
Karine Miquel ◽  
François Gaubert ◽  
Etienne Hollande ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document